International Society for Human and Animal Mycology (ISHAM)-New Initiatives.
diagnosis
epidemiology
management
mycoses
Journal
Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827
Informations de publication
Date de publication:
30 Jun 2020
30 Jun 2020
Historique:
received:
04
06
2020
revised:
23
06
2020
accepted:
23
06
2020
entrez:
8
7
2020
pubmed:
8
7
2020
medline:
8
7
2020
Statut:
epublish
Résumé
Fungal infections have emerged as major threat to human beings. The world is not ready to face this formidable challenge due to limited awareness, insufficient laboratories, and difficulty in managing mycoses especially in developing countries. The International Society for Human and Animal Mycology (ISHAM) has undertaken several new initiatives to overcome these gaps, including a global outreach program with national affiliated mycology societies and other regional groups. ISHAM is working closely with the European Confederation of Medical Mycology (ECMM) and Global Action Fund for Fungal Infections (GAFFI) to enhance these efforts. The society has launched laboratory e-courses and is in the process of the development of clinical e-courses. ISHAM has partnered with regional conferences in South America and Asia by sponsoring international experts and young delegates. The society also supports young people from less developed countries to undergo training in laboratories of excellence. ISHAM facilitated the formation of the INFOCUSLatin American Clinical Mycology Working Group (LATAM) and the Pan-African Mycology Working Group. The society appointed country ambassadors to facilitate coordination with national societies. Still, the task is enormous and ISHAM calls for strong advocacy and more coordinated activities to attract the attention of people from all disciplines to this neglected field.
Identifiants
pubmed: 32630110
pii: jof6030097
doi: 10.3390/jof6030097
pmc: PMC7557397
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
N Engl J Med. 2005 Sep 15;353(11):1185-6
pubmed: 16162897
mSphere. 2018 Jan 17;3(1):
pubmed: 29359190
Mycoses. 2018 Jul;61(7):477-484
pubmed: 29577447
Sci Transl Med. 2012 Dec 19;4(165):165rv13
pubmed: 23253612
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29530857
Mycoses. 2019 Apr;62(4):368-373
pubmed: 30614600
Mycoses. 2019 Apr;62(4):336-356
pubmed: 30561859
Indian J Dermatol. 2017 May-Jun;62(3):227-236
pubmed: 28584364
mBio. 2020 May 5;11(3):
pubmed: 32371596
Emerg Infect Dis. 2007 Jan;13(1):42-50
pubmed: 17370514
Clin Microbiol Rev. 2017 Nov 15;31(1):
pubmed: 29142078
Nature. 2012 Apr 11;484(7393):186-94
pubmed: 22498624
PLoS One. 2013 Aug 07;8(8):e71148
pubmed: 23940707
Int J Infect Dis. 2020 Jun;95:471-480
pubmed: 31945491
Lancet Infect Dis. 2017 Nov;17(11):e367-e377
pubmed: 28774696
Clin Microbiol Infect. 2020 Jul;26(7):944.e9-944.e15
pubmed: 31811914
Med Mycol. 2018 Jun 1;56(4):416-425
pubmed: 29036605
J Clin Microbiol. 2015 Jun;53(6):1823-30
pubmed: 25809970
J Infect. 2019 Aug;79(2):167-173
pubmed: 31233810
J Fungi (Basel). 2019 Jul 20;5(3):
pubmed: 31330862
Expert Rev Anti Infect Ther. 2020 Jun;18(6):551-562
pubmed: 32237924